A first-in-human phase I study of ATR inhibitor M1774 in patients with solid tumors

MLA

Andreas Becker, et al. “A First-in-Human Phase I Study of ATR Inhibitor M1774 in Patients with Solid Tumors.” Journal of Clinical Oncology, vol. 39, May 2021, p. TPS3153. EBSCOhost, https://doi.org/10.1200/jco.2021.39.15_suppl.tps3153.

APA

Andreas Becker, Ioannis Gounaris, Anthony W. Tolcher, Patricia Fleuranceau-Morel, Timothy A. Yap, Giuseppe Locatelli, Thomas Goddemeier, Elizabeth Ruth Plummer, & Johann S. de Bono. (2021). A first-in-human phase I study of ATR inhibitor M1774 in patients with solid tumors. Journal of Clinical Oncology, 39, TPS3153. https://doi.org/10.1200/jco.2021.39.15_suppl.tps3153

Chicago

Andreas Becker, Ioannis Gounaris, Anthony W. Tolcher, Patricia Fleuranceau-Morel, Timothy A. Yap, Giuseppe Locatelli, Thomas Goddemeier, Elizabeth Ruth Plummer, and Johann S. de Bono. 2021. “A First-in-Human Phase I Study of ATR Inhibitor M1774 in Patients with Solid Tumors.” Journal of Clinical Oncology 39 (May): TPS3153. doi:10.1200/jco.2021.39.15_suppl.tps3153.